Losing memory is a hallmark of Alzheimer's, a symptom of the disease that depletes a patient's quality of life. Improving…
Read More
Novel drug attenuates inflammation and disease activity in animal model of multiple sclerosis
MS is a chronic progressive autoimmune disease of central nervous system, which leads to neurological impairment and permanent clinical disability….
Read More
APO-Riluzole
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-RILUZOLE TABLETS Contains the active ingredient riluzole…
Read More
Being bilingual may help protect cognitive decline in multiple sclerosis patients
Bilingual speakers may benefit from protection against cognitive decline in multiple sclerosis according to a new study. In the first…
Read More
Vaccinations not a risk factor for multiple sclerosis
Data from over 12,000 multiple sclerosis (MS) patients formed the basis of a study by the Technical University of Munich…
Read More
Cognitive consequences worse for pediatric-onset multiple sclerosis
(HealthDay)—Patients with pediatric-onset multiple sclerosis (POMS) have a more rapid reduction in information-processing efficiency over time in adulthood, and they…
Read More
Multiple sclerosis patients’ brains cells are DECADES too old
Multiple sclerosis patients have brain cells that ‘look and act’ DECADES older than they should be as scientists hope the…
Read More
Stem cell transplant slows progression of multiple sclerosis
(HealthDay)—For patients with relapsing-remitting multiple sclerosis (MS), nonmyeloablative hematopoietic stem cell transplantation (HCST) is associated with prolonged time to disease…
Read More
Stem Cell Transplant Slows Progression of Multiple Sclerosis
TUESDAY, Jan. 15, 2019 — For patients with relapsing-remitting multiple sclerosis (MS), nonmyeloablative hematopoietic stem cell transplantation (HCST) is associated…
Read More